4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-033603
Options or other derivatives
- Chief Financial Officer acquired 63,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Emany Sravan Kumar Chief Financial Officer | 2026-01-31 | Grant or award · Stock Option (Right to Buy) | +63,500 | 63,500 | D | ||
Loading xslF345X05/ownership.xml…